The European Commission opened, on Wednesday 25 March, an in-depth investigation into the proposed acquisition of Tachosil by Johnson & Johnson.
The Commission is concerned that the merger may reduce potential competition and innovation for the supply of dual haemostatic patches.
For Margrethe Vestager, Executive Vice-President for Competition Policy, "in this concentrated space, we need to carefully assess whether the proposed merger would lead to reduced choice for surgeons and patients,...